Biotech

All Articles

Aelis' cannabis usage medication fails period 2b, steering Indivior to review $100M option

.Aelis Farma's hopes of securing an easy, good selection on a $100 million alternative repayment hav...

ProKidney halts period 3 trial not needed for tissue treatment confirmation

.ProKidney has actually stopped among a pair of period 3 trials for its cell treatment for renal hea...

Vaxcyte rises on 'stunning' 31-valent PCV win against Pfizer

.Vaxcyte introduced what experts called "spectacular" period 1/2 data for its 31-valent pneumococcal...

Recursion's human brain condition test presents little proof of efficacy

.Recursion has discovered via an early exam of its tech-enabled method to medicine revelation, repor...

Acepodia, Pfizer click on together for chemistry-based cell therapy

.Call it a situation of excellent chemistry: Acepodia, a biotech based on Nobel Champion science, is...

Praxis epilepsy drug reduces confiscations in period 2 trial

.Praxis Preciseness Medicines has actually scored another midphase succeed in epilepsy this year, wi...

Three directors resign as Dyne articles mixed data for DMD applicant

.After leaving a medical hold numerous years back, Dyne Therapeutics has actually revealed brand-new...

Arrowhead fires off period 3 information in rare metabolic condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has actually presented its own give ahead of a possible showdown along wi...

Pfizer, Valneva present lyme illness shot successful for 2nd enhancer

.Pfizer and also Valneva might have regarding 2 even more years to wait just before they make the ve...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's study a discussion along with Ayla Ellison, Intense Biotech Editor-in-Chief and also Michelle...